Serum granulysin is a marker for Th1 type immunity in pre-eclampsia

Clin Exp Immunol. 2004 Apr;136(1):114-9. doi: 10.1111/j.1365-2249.2004.02414.x.

Abstract

Recent studies suggest that pre-eclampsia is associated with a Th1 predominant state and may be considered a failure of tolerance. Granulysin is a cytotoxic granule protein of natural killer (NK) cells and cytotoxic T lymphocytes (CTLs). Recently, we developed an enzyme-linked immunosorbent assay (ELISA) system for detecting serum granulysin, and reported that serum granulysin is a useful marker to evaluate the cell-mediated immunity. In this study, we show that the serum levels of granulysin were significantly elevated in pre-eclamptic patients compared with those in normal pregnancy subjects. In addition, the serum granulysin levels in pre-eclamptic patients were well associated with mean blood pressure, percentage of peripheral blood Th1 cells and Th1/Th2 ratios. The present results suggest that the serum granulysin levels would be a useful and novel serum marker to evaluate the Th1/Th2 balance, especially Th1 type immunity in pre-eclampsia.

MeSH terms

  • Adult
  • Antigens, Differentiation, T-Lymphocyte / blood*
  • Biomarkers / blood
  • Female
  • Humans
  • Immunity, Cellular
  • Killer Cells, Natural / immunology
  • Pre-Eclampsia / immunology*
  • Pregnancy / blood
  • Th1 Cells / immunology*
  • Th2 Cells / immunology

Substances

  • Antigens, Differentiation, T-Lymphocyte
  • Biomarkers
  • GNLY protein, human